Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200396196> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4200396196 abstract "Abstract Background Glioblastoma is the deadliest type of primary brain tumor with a high rate of recurrence and treatment resistance. Hypoxia contributed much to radiotherapy resistance and chemoresistance of cancer. Ferroptosis is a nonapoptotic, oxidative cell death and identified as a potential anticancer mechanism in recent years. Erastin acts as a ferroptosis activator and shows a potential role in tumor treatment but the relationship between hypoxia and erastin resistance in glioblastoma has not been explained. This study aimed to investigate the role and underlying mechanism of hypoxia in erastin-induced ferroptosis in glioblastoma. Methods Cell proliferation and viability were determined by Cell Counting Kit-8 (CCK-8) assay, flow cytometry, TUNEL assays, and clone formation assay. Lipid peroxides level was analyzed by Malondialdehyde (MDA) assay and flow cytometry using C11-BODIPY dye. The correlation between HIF-1α and GPX4 expression was detected in data from the TCGA database and was determined by ChIP-qPCR assay and luciferase reporter assay. Subcutaneous xenograft and orthotopic xenograft models were established to test our findings in vivo. Results Hypoxia for at least 16 hours significantly suppressed erastin-induced ferroptosis by up-regulating glutathione peroxidase 4 (GPX4) expression in U87 and U251 cells. Hypoxia promotes GPX4 expression via enhancing the PI3K/AKT/HIF-1α pathway. Mechanistically, HIF-1α directly bound to the GPX4 gene promoter region and promoted GPX4 transcription. AKT inhibitor MK-2206 and HIF-1α inhibitor PX-478 could significantly reverse the effect. Besides, under normoxia, PX-478 could induce a higher lipid peroxidation level by decreasing GPX4 expression in U87 and U251 cells but cannot induced cell death directly, and it could significantly enhance the tumor cell killing effect of erastin. In vivo, combination of PX-478 and erastin had a coordinated intensification effect on anticancer activity uncovered by subcutaneous xenograft and orthotopic xenograft mouse models. Conclusions Hypoxia enhanced glioblastoma resistance to erastin-induced ferroptosis by activating PI3K/AKT/HIF-1α pathway and promoting GPX4 expression in a transcriptional regulation way. Combination therapy of PX-478 and erastin may be a potential strategy against glioblastoma." @default.
- W4200396196 created "2021-12-31" @default.
- W4200396196 creator A5019694172 @default.
- W4200396196 creator A5026464336 @default.
- W4200396196 creator A5029015570 @default.
- W4200396196 creator A5033702023 @default.
- W4200396196 creator A5039225458 @default.
- W4200396196 creator A5044290349 @default.
- W4200396196 creator A5063743958 @default.
- W4200396196 creator A5065037360 @default.
- W4200396196 date "2021-12-08" @default.
- W4200396196 modified "2023-10-16" @default.
- W4200396196 title "Hypoxia Enhanced Glioblastoma Resistance to Erastin-Induced Ferroptosis by Up-Regulating GPX4 via PI3K/AKT/HIF-1α Axis" @default.
- W4200396196 doi "https://doi.org/10.21203/rs.3.rs-1122453/v1" @default.
- W4200396196 hasPublicationYear "2021" @default.
- W4200396196 type Work @default.
- W4200396196 citedByCount "0" @default.
- W4200396196 crossrefType "posted-content" @default.
- W4200396196 hasAuthorship W4200396196A5019694172 @default.
- W4200396196 hasAuthorship W4200396196A5026464336 @default.
- W4200396196 hasAuthorship W4200396196A5029015570 @default.
- W4200396196 hasAuthorship W4200396196A5033702023 @default.
- W4200396196 hasAuthorship W4200396196A5039225458 @default.
- W4200396196 hasAuthorship W4200396196A5044290349 @default.
- W4200396196 hasAuthorship W4200396196A5063743958 @default.
- W4200396196 hasAuthorship W4200396196A5065037360 @default.
- W4200396196 hasBestOaLocation W42003961961 @default.
- W4200396196 hasConcept C102230213 @default.
- W4200396196 hasConcept C104317684 @default.
- W4200396196 hasConcept C153911025 @default.
- W4200396196 hasConcept C158086472 @default.
- W4200396196 hasConcept C181199279 @default.
- W4200396196 hasConcept C185592680 @default.
- W4200396196 hasConcept C190283241 @default.
- W4200396196 hasConcept C2778760513 @default.
- W4200396196 hasConcept C2780940892 @default.
- W4200396196 hasConcept C502942594 @default.
- W4200396196 hasConcept C53227056 @default.
- W4200396196 hasConcept C538909803 @default.
- W4200396196 hasConcept C553184892 @default.
- W4200396196 hasConcept C55493867 @default.
- W4200396196 hasConcept C75217442 @default.
- W4200396196 hasConcept C86554907 @default.
- W4200396196 hasConcept C86803240 @default.
- W4200396196 hasConceptScore W4200396196C102230213 @default.
- W4200396196 hasConceptScore W4200396196C104317684 @default.
- W4200396196 hasConceptScore W4200396196C153911025 @default.
- W4200396196 hasConceptScore W4200396196C158086472 @default.
- W4200396196 hasConceptScore W4200396196C181199279 @default.
- W4200396196 hasConceptScore W4200396196C185592680 @default.
- W4200396196 hasConceptScore W4200396196C190283241 @default.
- W4200396196 hasConceptScore W4200396196C2778760513 @default.
- W4200396196 hasConceptScore W4200396196C2780940892 @default.
- W4200396196 hasConceptScore W4200396196C502942594 @default.
- W4200396196 hasConceptScore W4200396196C53227056 @default.
- W4200396196 hasConceptScore W4200396196C538909803 @default.
- W4200396196 hasConceptScore W4200396196C553184892 @default.
- W4200396196 hasConceptScore W4200396196C55493867 @default.
- W4200396196 hasConceptScore W4200396196C75217442 @default.
- W4200396196 hasConceptScore W4200396196C86554907 @default.
- W4200396196 hasConceptScore W4200396196C86803240 @default.
- W4200396196 hasLocation W42003961961 @default.
- W4200396196 hasOpenAccess W4200396196 @default.
- W4200396196 hasPrimaryLocation W42003961961 @default.
- W4200396196 hasRelatedWork W2037885504 @default.
- W4200396196 hasRelatedWork W2362061149 @default.
- W4200396196 hasRelatedWork W2380401997 @default.
- W4200396196 hasRelatedWork W2384173773 @default.
- W4200396196 hasRelatedWork W2385169010 @default.
- W4200396196 hasRelatedWork W2411921067 @default.
- W4200396196 hasRelatedWork W2949555002 @default.
- W4200396196 hasRelatedWork W2981184832 @default.
- W4200396196 hasRelatedWork W3169218168 @default.
- W4200396196 hasRelatedWork W4220828136 @default.
- W4200396196 isParatext "false" @default.
- W4200396196 isRetracted "false" @default.
- W4200396196 workType "article" @default.